These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7363400)
1. Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer. Rubens RD; King RJ; Sexton S; Minton MJ; Hayward JL Cancer Chemother Pharmacol; 1980; 4(1):43-5. PubMed ID: 7363400 [TBL] [Abstract][Full Text] [Related]
2. Implications of oestrogen receptor status in primary breast carcinoma to the role of adjuvant chemotherapy in node-negative cases. Hartveit F; Støa KF; Tangen M Oncology; 1981; 38(4):219-21. PubMed ID: 7243174 [TBL] [Abstract][Full Text] [Related]
3. Oestrogen receptor status and survival in Chinese females with breast cancer. Alagaratnam TT; Wei WI; Cheung SY; Ong GB Aust N Z J Surg; 1982 Dec; 52(6):601-4. PubMed ID: 6187322 [TBL] [Abstract][Full Text] [Related]
4. Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Lippman ME; Allegra JC Cancer; 1980 Dec; 46(12 Suppl):2829-34. PubMed ID: 7448729 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer. Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144 [TBL] [Abstract][Full Text] [Related]
6. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Gazet JC; Coombes RC; Ford HT; Griffin M; Corbishley C; Makinde V; Lowndes S; Quilliam J; Sutcliffe R Br J Cancer; 1996 Mar; 73(6):758-62. PubMed ID: 8611376 [TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen. Holdaway IM Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051 [TBL] [Abstract][Full Text] [Related]
8. Lack of estrogen receptor associated with an increased response rate to cytotoxic chemotherapy in metastatic breast cancer? Lippman ME; Allegra JC Recent Results Cancer Res; 1980; 71():155-61. PubMed ID: 7367728 [TBL] [Abstract][Full Text] [Related]
9. Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist. Gahlaut R; Bennett A; Fatayer H; Dall BJ; Sharma N; Velikova G; Perren T; Dodwell D; Lansdown M; Shaaban AM Eur J Cancer; 2016 Jun; 60():40-8. PubMed ID: 27062316 [TBL] [Abstract][Full Text] [Related]
10. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer. Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer. Rubens RD; Hayward JL Cancer; 1980 Dec; 46(12 Suppl):2922-4. PubMed ID: 7448737 [TBL] [Abstract][Full Text] [Related]
12. Does the oestrogen receptor concentration of a breast cancer change during systemic therapy? Hawkins RA; Tesdale AL; Anderson ED; Levack PA; Chetty U; Forrest AP Br J Cancer; 1990 Jun; 61(6):877-80. PubMed ID: 2372489 [TBL] [Abstract][Full Text] [Related]
13. Pre-operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates. Crawford DJ; Lope-Pihie A; Cowan S; George WD; Leake RE Br J Surg; 1985 Dec; 72(12):991-3. PubMed ID: 3910164 [TBL] [Abstract][Full Text] [Related]
14. Receptors in the management of breast cancer. Hawkins RA Br J Hosp Med; 1985 Sep; 34(3):160-4. PubMed ID: 2415195 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience. Rosenbaum C; Marsland TA; Stolbach LL; Raam S; Cohen JL Cancer; 1980 Dec; 46(12 Suppl):2919-21. PubMed ID: 7448736 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy. Samal BA; Brooks SC; Cummings G; Franco L; Hire EA; Martino S; Singhakowinta A; Vaitkevicius VK Cancer; 1980 Dec; 46(12 Suppl):2925-7. PubMed ID: 7004629 [TBL] [Abstract][Full Text] [Related]
17. Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer. Jones RL; Salter J; A'Hern R; Nerurkar A; Parton M; Reis-Filho JS; Smith IE; Dowsett M Breast Cancer Res Treat; 2010 Jan; 119(2):315-23. PubMed ID: 19247830 [TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor assay in primary breast cancer: clinical validation and prognostic value. Furnival CM; Hillyard NC; Gough IR Aust N Z J Surg; 1982 Aug; 52(4):403-8. PubMed ID: 6956317 [TBL] [Abstract][Full Text] [Related]
19. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]. Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808 [TBL] [Abstract][Full Text] [Related]
20. The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Hilf R; Feldstein ML; Gibson SL; Savlov ED Cancer; 1980 Apr; 45(8):1993-2000. PubMed ID: 7370949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]